Answers are grounded in this paper and cite their sources.
By analyzing both single-nucleotide polymorphisms for the first time, we convincingly show that indeed FSHR 2039A>G has an effect also in males. In the proposed model of the combined effects, FSHB -211G>T acts strongly on male reproductive parameters, whereas the FSHR 2039A>G effects were approximately 2-3 times smaller. Clinically this is of importance because oligozoospermic patients carrying unfavorable variants affecting FSH action may benefit from FSH treatment.
No takes yet. Share an insight, caveat, or question.
Tüttelmann et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: